These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1542 related items for PubMed ID: 17013474

  • 21. [Vaccination against viral hepatitis A and B in adults aged over 40 years--antibody persistence and immune memory].
    Chlibek R, Smetana J, Bostíková V, Splino M.
    Epidemiol Mikrobiol Imunol; 2011 Sep; 60(3):99-108. PubMed ID: 22132651
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Vaccination against hepatitis A virus may not be required for schoolchildren in northern India: results of a seroepidemiological survey.
    Batra Y, Bhatkal B, Ojha B, Kaur K, Saraya A, Panda SK, Acharya SK.
    Bull World Health Organ; 2002 Sep; 80(9):728-31. PubMed ID: 12378291
    [Abstract] [Full Text] [Related]

  • 24. The prevalence of atopy in children with antibodies against hepatitis A virus and hepatitis B virus.
    Kocabaş E, Yapicioğlu H, Yildizdaş D, Güneşer Kendirli S, Burgut R.
    Turk J Pediatr; 2006 Sep; 48(3):189-96. PubMed ID: 17172060
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Should Brazilian patients with chronic hepatitis C virus infection be vaccinated against hepatitis A virus?
    Villar LM, de Melo MM, Calado IA, de Almeida AJ, Lampe E, Gaspar AM.
    J Gastroenterol Hepatol; 2009 Feb; 24(2):238-42. PubMed ID: 19215334
    [Abstract] [Full Text] [Related]

  • 28. High prevalence of hepatitis A virus antibody among Bangladeshi children and young adults warrants pre-immunization screening of antibody in HAV vaccination strategy.
    Ahmed M, Munshi SU, Nessa A, Ullah MS, Tabassum S, Islam MN.
    Indian J Med Microbiol; 2009 Feb; 27(1):48-50. PubMed ID: 19172060
    [Abstract] [Full Text] [Related]

  • 29. [Prevalence of serological markers of viral hepatitis A, B and delta in apparently healthy schoolchildren of Huanta, Peru].
    Cabezas C, Gotuzzo E, Escamilla J, Phillips I.
    Rev Gastroenterol Peru; 1994 Feb; 14(2):123-34. PubMed ID: 7948940
    [Abstract] [Full Text] [Related]

  • 30. Kawerau revisited: hepatitis A and B seroprevalence in 1984 and 1993.
    Lucas CR, Milne A, Hopkirk N.
    N Z Med J; 1994 Jul 13; 107(981):266-8. PubMed ID: 8022582
    [Abstract] [Full Text] [Related]

  • 31. Seroepidemiology of hepatitis A virus infection among schoolchildren in Taiwan.
    Tsai CF, Lin DB, Chen SC, Chang YH, Chen CY, Lin JB.
    J Med Virol; 2011 Feb 13; 83(2):196-200. PubMed ID: 21181912
    [Abstract] [Full Text] [Related]

  • 32. Seroprevalence of hepatitis A virus antibodies in Turkish and Moroccan children in Rotterdam.
    Richardus JH, Vos D, Veldhuijzen IK, Groen J.
    J Med Virol; 2004 Feb 13; 72(2):197-202. PubMed ID: 14695660
    [Abstract] [Full Text] [Related]

  • 33. Differences in hepatitis A seroprevalence among geographical regions in Turkey: a need for regional vaccination recommendations.
    Ceyhan M, Yildirim I, Kurt N, Uysal G, Dikici B, Ecevit C, Aydogan A, Koc A, Yasa O, Köseoğlu M, Onal K, Hacimustafaoglu M, Celebi S.
    J Viral Hepat; 2008 Oct 13; 15 Suppl 2():69-72. PubMed ID: 18837839
    [Abstract] [Full Text] [Related]

  • 34. Long-term protection of hepatitis B vaccine 18 years after vaccination.
    Alfaleh F, Alshehri S, Alansari S, Aljeffri M, Almazrou Y, Shaffi A, Abdo AA.
    J Infect; 2008 Nov 13; 57(5):404-9. PubMed ID: 18829116
    [Abstract] [Full Text] [Related]

  • 35. Prevalence of markers of hepatotropic viruses A, B, C and the efficacy of vaccination against hepatitis A and hepatitis B among medical students.
    Jabłkowski M, Kuydowicz J, Strzelczyk J, Białkowska J.
    Med Sci Monit; 2002 Nov 13; 8(11):CR762-6. PubMed ID: 12444381
    [Abstract] [Full Text] [Related]

  • 36. Seroprevalence of Hepatitis-B infection amongst Taiwanese university students 18 years following the commencement of a national Hepatitis-B vaccination program.
    Su FH, Chen JD, Cheng SH, Lin CH, Liu YH, Chu FY.
    J Med Virol; 2007 Feb 13; 79(2):138-43. PubMed ID: 17177303
    [Abstract] [Full Text] [Related]

  • 37. Immunogenicity of two paediatric doses of monovalent hepatitis B or combined hepatitis A and B vaccine in 8-10-year-old children.
    Duval B, Gîlca V, Boulianne N, Deceuninck G, Rochette L, De Serres G.
    Vaccine; 2005 Jul 01; 23(31):4082-7. PubMed ID: 15963363
    [Abstract] [Full Text] [Related]

  • 38. Antibody titers and response to vaccination against hepatitis A and B in pediatric patients with portal hypertension.
    Rosa MN, Hessel G, Alves De Tommaso AM.
    Acta Gastroenterol Latinoam; 2008 Sep 01; 38(3):187-93. PubMed ID: 18979898
    [Abstract] [Full Text] [Related]

  • 39. Prevalence of hepatitis B virus markers among blood donors in a tertiary hospital in Tabuk, northwestern Saudi Arabia.
    El Beltagy KE, Al Balawi IA, Almuneef M, Memish ZA.
    Int J Infect Dis; 2008 Sep 01; 12(5):495-9. PubMed ID: 18400539
    [Abstract] [Full Text] [Related]

  • 40. Prevalence of hepatitis A and B markers and vaccine indication in cirrhotic patients evaluated for liver transplantation in Spain.
    Aoufi S, Pascasio JM, Sousa JM, Sayago M, Ferrer MT, Gómez-Delgado E, De la Cruz MD, Alamo JM, Gómez-Bravo MA, Bernardos A, Márquez JL.
    Transplant Proc; 2008 Nov 01; 40(9):2946-8. PubMed ID: 19010155
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 78.